Walgreens and Mental Health America are collaborating on MHA’s “back to school campaign,” which includes a comprehensive set of new resources that will be available at no cost this coming ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, reflects on the company’s three-year evolution as a clinical trials partner, highlighting its pharmacy-led model and ...

Walgreens previously said it was withdrawing its fiscal-year outlook after reaching a take-private deal with Sycamore Partners.

2. Walgreens is branching out into the healthcare space. In addition to growing its core business, Walgreens is also building a healthcare initiative that was originally called Walgreens Health ...

Walgreens says clinical trials inclusive of diverse communities are critical to improving health outcomes, especially in cancer research. Cancer claims nearly 2,000 lives daily in the United ...

An internal medicine physician, Dr. Moodley joined the U.S. Healthcare team in 2021 as chief clinical officer, tasked with designing the care model and clinical strategy for Walgreens' expansion ...

Walgreens is historically more consumer-centric than traditional healthcare providers, Driscoll noted, and the company uses data to profile customers based on culture, language and psychographics.

John Driscoll, who has been Walgreens’ executive vice president and president of U.S. health care since 2022, is transitioning to a paid senior advisory role, according to a Feb. 8 statement.

Walgreens Boots Alliance revealed today that it significantly overpaid for VillageMD, a primary care asset once touted as the lynchpin of Walgreens’ health care ambitions, disclosing a nearly $6 ...